Breaking News

Cryoport’s MVE Biological Solutions Registers Mfg. Facilities with FDA

Adheres to requirements, including 21 CFR Part 820 and Good Manufacturing Practices.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Image: MVE Biological Solutions

Cryoport, Inc., a global supply chain solutions provider for the life sciences industry, announced that MVE Biological Solutions, a Cryoport company and global manufacturer of high-quality cryogenic freezers and dewars, has registered all three of its manufacturing facilities (located in Ball Ground, Georgia; New Prague, Minnesota; and Chengdu, China) with the U.S. FDA. Additionally, all applicable MVE-manufactured cryogenic freezers and dewars are now listed with the FDA. To meet the standar...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters